These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The management of glaucoma in nanophthalmos. Calhoun FP Trans Am Ophthalmol Soc; 1975; 73():97-122. PubMed ID: 1246819 [TBL] [Abstract][Full Text] [Related]
3. Prevalence of complications in eyes with nanophthalmos or microphthalmos: protocol for a systematic review and meta-analysis. Ally N; Ismail S; Alli HD Syst Rev; 2022 Feb; 11(1):25. PubMed ID: 35139896 [TBL] [Abstract][Full Text] [Related]
5. Nanophthalmos with uveal effusion. A new clinical entity. Brockhurst RJ Arch Ophthalmol; 1975 Dec; 93(12):1989-99. PubMed ID: 1200903 [TBL] [Abstract][Full Text] [Related]
6. Laser and unsutured sclerotomy in nanophthalmos. Jin JC; Anderson DR Am J Ophthalmol; 1990 May; 109(5):575-80. PubMed ID: 2333921 [TBL] [Abstract][Full Text] [Related]
8. Retinitis pigmentosa, nanophthalmos, and optic disc drusen: a case report. Buys YM; Pavlin CJ Ophthalmology; 1999 Mar; 106(3):619-22. PubMed ID: 10080224 [TBL] [Abstract][Full Text] [Related]
9. Choroidal effusion following laser peripheral iridotomy for the treatment of angle closure glaucoma in a patient with nanophthalmos. Thapa SS; Paudyal G Nepal Med Coll J; 2005 Jun; 7(1):81-2. PubMed ID: 16295732 [TBL] [Abstract][Full Text] [Related]
10. Familial nanophthalmos: management and complications. Neelakantan A; Venkataramakrishnan P; Rao BS; Krishnan N; Vijaya L; John S; Kar B Indian J Ophthalmol; 1994 Sep; 42(3):139-43. PubMed ID: 7829177 [TBL] [Abstract][Full Text] [Related]
12. Nanophthalmos: a perspective on identification and therapy. Singh OS; Simmons RJ; Brockhurst RJ; Trempe CL Ophthalmology; 1982 Sep; 89(9):1006-12. PubMed ID: 7177565 [TBL] [Abstract][Full Text] [Related]
13. Rapid resolution of severe exudation in uveal effusion syndrome with anti-vascular endothelial growth factor alone in a case of bilateral nanophthalmos: a case report. Song L; Dong F; Yi C J Med Case Rep; 2021 Oct; 15(1):515. PubMed ID: 34663453 [TBL] [Abstract][Full Text] [Related]
14. Nanophthalmos with uveal effusion: clinical and embryologic considerations. Ryan EA; Zwaan J; Chylack LT Ophthalmology; 1982 Sep; 89(9):1013-7. PubMed ID: 7177566 [TBL] [Abstract][Full Text] [Related]
15. Extensive circumferential partial-thickness sclerectomy in eyes with extreme nanophthalmos and spontaneous uveal effusion. Mansour A; Stewart MW; Shields CL; Hamam R; Abdul Fattah M; Sheheitli H; Mehanna CJ; Yassine S; Chahine H; Keaik M; Maalouf F; Jaroudi M Br J Ophthalmol; 2019 Dec; 103(12):1862-1867. PubMed ID: 30877130 [TBL] [Abstract][Full Text] [Related]
16. Nanophthalmos in sisters, one with exfoliation syndrome. Diehl DL; Feldman F; Tanzer H; Shea M Can J Ophthalmol; 1989 Dec; 24(7):327-30. PubMed ID: 2696577 [TBL] [Abstract][Full Text] [Related]
17. Two cases of uveal effusion syndrome. Lee JH; Choi JY; Kim SS Korean J Ophthalmol; 2006 Jun; 20(2):124-7. PubMed ID: 16892650 [TBL] [Abstract][Full Text] [Related]
18. A unique case of bilateral nanophthalmos and pigmentary retinal abnormality with unilateral angle closure glaucoma and optic disc pit. Garg P; Kumar B; Dubey S BMC Ophthalmol; 2023 Sep; 23(1):391. PubMed ID: 37752465 [TBL] [Abstract][Full Text] [Related]
19. Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report. Li Y; Zhou Q BMC Ophthalmol; 2023 Oct; 23(1):405. PubMed ID: 37814274 [TBL] [Abstract][Full Text] [Related]
20. The management of secondary glaucoma in nanophthalmic patients. Huang S; Yu M; Qiu C; Ye T Yan Ke Xue Bao; 2002 Sep; 18(3):156-9. PubMed ID: 15510745 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]